|
|
|
|
|
|
|
|
|
|
|
16.05.26 - 13:06
|
New to The Street′s Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast, Stardust Power, Lost Soldier Oil and Gas, Virtuix Holdings, and Medicus Pharma (Accesswire)
|
|
|
The show broadcasts as sponsored programming featuring TV commercials from IGC Pharma, Inc. (NYSE American:IGC), NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), Medicus Pharma Ltd. (NASDAQ:MDCX), and Data......
|
|
|
|
|
|
|
14.05.26 - 13:06
|
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update (GlobeNewswire EN)
|
|
|
WILMINGTON, Del., May 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its first quarter 2026 financial results before the market opens on Monday, May 18, 2026 via press release, which will be available on the Company's website at https://ir.nrxpharma.com/. The Company will host a conference call at 8:00am ET the same day....
|
|
|
|
|
|
|
15.04.26 - 13:03
|
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications (GlobeNewswire EN)
|
|
|
MIAMI, April 15, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the incorporation of NRx Defense Systems, Inc., a Florida-based Research and Development subsidiary. The subsidiary is charged with development of neuroplastic treatments that combine D-cycloserine with Transcranial Magnetic Stimulation (TMS) under robotic-enabled neuro-navigation, using already developed technology. The Company anticipates participating in future government and non-governmental research and development on a basis that is non-dilutive to current shareholders....
|
|
|
|
|
06.04.26 - 13:03
|
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx′s Preservative-Free Ketamine Application (GlobeNewswire EN)
|
|
|
WILMINGTON, Del., April 06, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has received a letter from the Labeling Program of the FDA Office of Generic Drugs whose only comments were limited to minor formatting changes to the proposed label for the Company's preservative-free ketamine product. The Company expects to submit the final label this month. The determination is deemed preliminary until final supervisory review of NRx's Abbreviated New Drug Application with anticipated approval in Summer 2026....
|
|
|
30.03.26 - 13:03
|
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network (GlobeNewswire EN)
|
|
|
SARASOTA, Fla. and PARIS, March 30, 2026 (GLOBE NEWSWIRE) -- Hope Therapeutics, Inc. (“Hope”), a subsidiary of NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), today announced a strategic partnership with Emobot Health to deploy its revolutionary AI-driven emotional monitoring platform across Hope's rapidly expanding network of interventional psychiatry clinics. This roll-out represents the first large-scale clinical integration of Emobot's "Depression Thermometer," a passive monitoring tool designed to detect early treatment response and prevent relapse in patients with Treatment-Resistant Depression (TRD)....
|
|
|
|
|
|
|
|
|
|
|
|
|
19.03.26 - 12:03
|
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026 (GlobeNewswire EN)
|
|
|
WILMINGTON, Del., March 19, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will host a conference call at 8:00am ET on Tuesday, March 24, 2026....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
